Fluoroquinolone antibiotic. Inhibits bacterial type II topoisomerases (IC50
values are 0.109 and 13.8 μ
g/ml for E.coli
DNA gyrase and S.aureus
topoisomerase IV respectively). Displays potent activity against gram-positive and gram-negative bacteria. Stimulates short-term self-renewal in both human and mouse embryonic stem cells in vitro
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Inhibitory activities of gatifloxacin (AM-1155), a newly developed fluoroquinolone, against bacterial and mammalian type II topoisomerases.
Takei et al.
Antimicrob.Agents Chemother., 1998;42:2678
Antibacterial activity of gatifloxacin (AM-1155, CG5501, BMS-206584), a newly developed fluoroquinolone, against sequentially acquired quinolone-resistant mutants and the norA transformant of Staphylococcus aureus.
Fukuda et al.
Antimicrob.Agents Chemother., 1998;42:1917
High throughput screening assay for the identification of compounds regulating self-renewal and differentiation in human embryonic stem cells.
Desbordes et al.
Cell Stem Cell, 2008;2:602